Treatment of congestive heart failure with growth hormone secretagogues
US6329342A · kind A · utility
16Cited by
23References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2000 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Feb 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods for the modulation of cardiac function which comprise the administration of certain compounds, as defined herein, having growth hormone secretagogue activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.